Atreca, Inc. Class A Common Stock
BCEL
BCEL was delisted on the 18th of March, 2024.
53 hedge funds and large institutions have $13.4M invested in Atreca, Inc. Class A Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 4 closing their positions.
120% more call options, than puts
Call options by funds: $11K | Put options by funds: $5K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less funds holding
Funds holding: 54 → 53 (-1)
18% less capital invested
Capital invested by funds: $16.3M → $13.4M (-$2.91M)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
50% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
+$77.2K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$51.5K |
| 3 |
Renaissance Technologies
New York
|
+$18.8K |
| 4 |
VF
Virtu Financial
New York
|
+$14.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$300K |
| 2 |
BlackRock
New York
|
-$158K |
| 3 |
GF
Gates Foundation
Seattle,
Washington
|
-$76.9K |
| 4 |
LCM
Laurion Capital Management
New York
|
-$64.9K |
| 5 |
Millennium Management
New York
|
-$60.1K |
BCEL Hedge Fund Activity: Q2 2023 in Review
53 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Atreca, Inc. Class A Common Stock (BCEL) for Q2 2023, worth a combined $13.4M — down 18% from $16.3M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BCEL and 3 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 7 added.
The largest buyer was CM Management, adding an estimated $77.2K. The largest seller was Samsara BioCapital, exiting entirely with an estimated $300K sold.
- 53 institutional investors held Atreca, Inc. Class A Common Stock (BCEL) as of Q2 2023, down from 54 in Q1 2023.
- Funds reported $13.4M of Atreca, Inc. Class A Common Stock stock for Q2 2023, down 18% quarter-over-quarter.
- 3 funds opened new Atreca, Inc. Class A Common Stock positions in Q2 2023 and 4 closed out, a net change of -1 holder.
- The largest Atreca, Inc. Class A Common Stock buyer in Q2 2023 was CM Management, an estimated $77.2K added.
- The largest Atreca, Inc. Class A Common Stock seller in Q2 2023 was Samsara BioCapital, an estimated $300K sold.
Based on aggregated 13F filings for Q2 2023.